We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+0.34%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$76.3B
AUM Growth
+$8.42B
(+12%)
Cap. Flow
+$9.49B
Cap. Flow
% of AUM
12.45%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
3,927
New
717
Increased
1,476
Reduced
1,083
Closed
513
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$402M |
| 2 |
Johnson & Johnson
JNJ
|
+$402M |
| 3 |
Coca-Cola
KO
|
+$375M |
| 4 |
HCA Healthcare
HCA
|
+$332M |
| 5 |
Tesla
TSLA
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Microsoft
MSFT
|
+$718M |
| 3 |
Spotify
SPOT
|
+$617M |
| 4 |
Bank of America
BAC
|
+$333M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.06% |
| 2 | Consumer Discretionary | 10.91% |
| 3 | Healthcare | 10.34% |
| 4 | Financials | 10.21% |
| 5 | Industrials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Context Therapeutics
CNTX
$54.3M
| $339K | ﹤0.01% |
322,838
+219,433
| +212% | +$380K |
|
2652
PUT
CSX Corp
CSX
$94.2B
| $339K | ﹤0.01% |
10,500
+5,700
| +119% | +$195K |
|
2653
Carlyle Secured Lending
CGBD
$719M
| $339K | ﹤0.01% |
18,887
-12,373
| -40% | -$213K |
|
2654
iShares Russell Top 200 Growth ETF
IWY
$15.6B
| $339K | ﹤0.01% |
1,439
+347
| +32% | +$79.7K |
|
2655
iShares S&P 100 ETF
OEF
$19.8B
| $338K | ﹤0.01% |
1,171
+516
| +79% | +$148K |
|
2656
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $338K | ﹤0.01% |
10,755
-6,747
| -39% | -$220K |
|
2657
PUT
Pultegroup
PHM
$25.7B
| $338K | ﹤0.01% |
3,100
+2,800
| +933% | +$364K |
|
2658
PUT
Caesars Entertainment
CZR
$6.1B
| $338K | ﹤0.01% |
+10,100
| New | +$400K |
|
|
PLGO
2659
Pelagos Insurance Capital
PLGO
$2.22B
| $337K | ﹤0.01% |
+18,592
| New | +$345K |
|
2660
CALL
L3Harris
LHX
$56.9B
| $336K | ﹤0.01% |
+1,600
| New | +$383K |
|
2661
iShares US Financials ETF
IYF
$4.74B
| $336K | ﹤0.01% |
3,036
+108
| +4% | +$12K |
|
2662
CALL
Interactive Brokers
IBKR
$40.5B
| $336K | ﹤0.01% |
+7,600
| New | +$320K |
|
|
LFT
2663
Lument Finance Trust
LFT
$41.3M
| $335K | ﹤0.01% |
129,834
+65,446
| +102% | +$168K |
|
2664
iShares MSCI USA Quality Factor ETF
QUAL
$46.2B
| $335K | ﹤0.01% |
1,881
-964
| -34% | -$175K |
|
|
WMPN
2665
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $335K | ﹤0.01% |
27,878
+12,179
| +78% | +$154K |
|
2666
Eagle Bancorp Montana
EBMT
$188M
| $334K | ﹤0.01% |
21,792
+9,075
| +71% | +$150K |
|
2667
Genasys
GNSS
$77M
| $334K | ﹤0.01% |
128,423
+49,923
| +64% | +$175K |
|
2668
PUT
NRG Energy
NRG
$26.9B
| $334K | ﹤0.01% |
3,700
-2,600
| -41% | -$241K |
|
2669
Fidelity MSCI Information Technology Index ETF
FTEC
$19.4B
| $333K | ﹤0.01% |
1,802
+1,633
| +966% | +$298K |
|
2670
CALL
Corning
GLW
$108B
| $333K | ﹤0.01% |
+7,000
| New | +$332K |
|
|
GAP
2671
CALL
The Gap Inc
GAP
$7.28B
| $331K | ﹤0.01% |
14,000
+8,800
| +169% | +$201K |
|
2672
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.51B
| $330K | ﹤0.01% |
11,364
-36,394
| -76% | -$1.13M |
|
|
SFBC
2673
Sound Financial Bancorp
SFBC
$105M
| $330K | ﹤0.01% |
6,269
+2,406
| +62% | +$129K |
|
2674
Hurco Companies Inc
HURC
$135M
| $330K | ﹤0.01% |
17,105
+6,895
| +68% | +$145K |
|
2675
Organogenesis Holdings
ORGO
$326M
| $330K | ﹤0.01% |
103,076
+65,734
| +176% | +$221K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2024 Portfolio in Review
As of Q4 2024, Qube Research & Technologies (QRT) held 3,927 positions worth $76.3B, up 12% from $67.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Qube Research & Technologies (QRT) deployed $9.49B of net new capital in Q4 2024, opening 717 new positions and adding to 1,476 existing holdings. Its largest new stake was Tesla: 1,023,779 shares worth $413M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2024 buy was Tesla: 1,023,779 shares worth $413M.
- Qube Research & Technologies (QRT) added most to Applied Materials in Q4 2024, an estimated $402M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2024 reduction was NVIDIA, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Honeywell in Q4 2024, selling an estimated $235M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 11% of its $76.3B portfolio in Q4 2024.
- Qube Research & Technologies (QRT) opened 717 new positions and closed 513 in Q4 2024.
- Qube Research & Technologies (QRT)'s portfolio value rose 12% quarter-over-quarter to $76.3B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.